CD28 and myeloid sarcoma: Given that cytolytic granzyme B-producing CD4+CD28- cells are shown to migrate to sites of inflammation in MS where they contribute to tissue damage so that their greater frequency correlates with worse clinical outcome [24,44,68], the frequency of granzyme B+ CD4+ T cells infiltrating SC of rats immunized for EAE was examined.